Tsunami Drug Donations in Sri Lanka: Have the WHO Guidelines on Drug Donations been Effective in Meeting Public Health Pharmaceutical Needs in Times of.

Slides:



Advertisements
Similar presentations
Basic Principles of GMP
Advertisements

Fundamentals of Pharmacology for Veterinary Technicians
Managing Compliance Related to Human Subjects Research Review Joseph Sherwin, Ph.D. Office of Regulatory Affairs University of Pennsylvania Fourth Annual.
Lebanon, 2004 Medicine price survey in Lebanon, 2004 undertaken by Dr Rita Karam, Ministry of Health Marg Ewen (on behalf of Dr Karam) WHO/HAI post-medicine.
1 Introduction to the medicine prices and availability survey and training workshop Presentation template for adaptation and use in medicine prices and.
Canadas Health Warning Messages for Tobacco Products Labelling a Legally Available, Inherently Harmful Product WTO Learning Event on Product Labelling.
Quality Assurance Processes for TB Drugs. GDF Quality Assurance Processes.
Combating Counterfeit Drugs in China Chen Xu Ph.D. Director of Division of Drug Supervision and Inspection Department of Drug Market.
WHO Good Distribution Practices for Pharmaceutical Products
WHO - PSM Documentation – Part 2 Workshop on GMP and Quality Assurance of TB products Kuala Lumpur Malaysia, 21 – 25 February 2005 Maija Hietava M.Sci.Pharm.
Policy on Quality Assurance for Single and Limited- Source Pharmaceuticals Nairobi, Kenya, 20 – 24 February 2006.
For Official Use Only. Public Health and EMS How Long Do You Have to Live? For Official Use Only.
Monitoring the Product Production, Import, Wholesale and Retail Level Monitoring.
NHS eProcurement Strategy Trade Association Meeting 24 th November 2014DH – Leading the nation’s health and care.
Jan Komrska & Alison Fleet
1 Household Survey on Medicine Use in Oman Ahmed Abdo-Rabbo, Manal Al- Ansari, Brian Gunn, Batool Suleiman & Hawraa Al-Lawati Directorate of Rational Use.
Introduction to Treat the Pain. The problem of unrelieved pain Globally, 7.3 million people die of cancer or HIV each year in moderate or severe pain.
Pharmacy Program Initiatives Threshold, Mandatory Generic, Maximum Allowable Cost (MAC) Javier Menendez, RPh Pharmacy Manager Department of Medical Assistance.
© 2005 Notification and Reporting on Food Incidents: Irish Approach Food & Drugs Authority Bangkok Thailand Dorothy Guina-Dornan.
UNICEF Medicines Supply Strengthening WHO Technical Briefing Seminar on Essential Medicines and Health Products Tuesday 29 October 2013 Technical Specialist.
Policies to Prevent Pharmaceutical Waste: Looking at Sample Waste Product Stewardship Institute, Inc. June 4, 2012.
Quality Medical Donations & Minimizing Drug Disposal Anthoula Randopoulos Vice President of Philanthropic Investment Direct Relief International.
Determination of Construction Contract Duration for Public Projects in Saudi Arabia By: Ahmed Saleh Al-Sultan, June 1989 Presented by Sameh Elish January.
Quality control of raw materials In-process control
IPC meeting June 2014 Dr Joelle DAVIAUD, Quality Assurance Specialist Model Quality Assurance System for procurement agencies.
Management of the Tuberculosis Drug Supply Module 13 – March 2010.
Optimizing medicines use to improve patient outcomes Guidelines on pharmaceutical donations; The case of KNH.
Huzairy Hassan School of Bioprocess Engineering UniMAP.
Documentation –Part 2 Basic Principles of GMP Pharmaceutical Quality,
World Health Organization
Whilst the pharmaceutical industry plays a key role in developing and producing medicines, there is a tension between industry’s need to expand product.
Business Statistics and Registers
Regulatory Update Ellen Leinfuss SVP, Life Sciences.
Federal Acquisition Service U.S. General Services Administration REPORTING PERSONAL PROPERTY FOR DISPOSAL Eddie Panko Area Property Officer January 2009.
Introduce on Imported Foods System in Korea - Under The Food Sanitation Act - Korea Food and Drug Administration.
Elizabeth McNulty Head of Incident Response Food Standards Agency.
Medicines Transparency Alliance01/10/2015 Availability of Medicines Anita Wagner Harvard Medical School & WHO Collaborating Center in Pharmaceutical Policy.
Railway Transport Equipment (RTE) Certification Railway Transport Equipment Certification Procedure Application for railway transport equipment certification.
By Professor Ranjit Roy Chaudhury WHO-SEA ACHR BANGKOK 12 October Quality of Research Supported by SEARO in countries of the Region.
The Pharmaceutical Situational Analysis in Mongolia 1 Chimedtseren Munkhdelger 1 Sanjjav Tsetsegmaa 2, 1 Ministry of Health, 2 Pharmacy School, Health.
Guidance on communication with respect to safe drinking water and household hygiene World Health Organisation Alison Parker Cranfield University All photographs.
Important informations
Policy track summary ICIUM 2011 – 18 Nov Policy track topics 1.The pharmaceutical policy process 2.Quality and safety of medicines in LMIC 3.Policy.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
The impact of systematic reviews on The impact of systematic reviews on Health Service: the CDAG Italian Health Service: the CDAG Italian experience experience.
Prepared by Michele Mascia “This workforce solution was funded by a grant awarded under Workforce Innovation in Regional Economic Development (WIRED) as.
Assessment of Interchangeable Multisource Medicines BCS-Biowaivers - Template Dr. Henrike Potthast Training workshop: Assessment of.
1 WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies Tuesday 1 November 2011 Technical Specialist Henrik K.Nielsen, Medicines and Nutrition.
Productivity Commission Capacity Building On Regulatory Review Impact Analysis Module ‘ Compliance costs: Business Cost Calculator’ March 2011 Rod.
Systems that support electronically executed business transactions.
Copyright © 2010 Delmar, Cengage Learning. ALL RIGHTS RESERVED. Chapter 23 and 24 Basic Pharmacology Medication Calculations Dosage.
Selection of essential medicines Richard Laing and Deidre Dimancesco TBS 2011 Department of Essential Medicines & Pharmaceutical Policies TBS 2008.
UNICEF Medicines Supply Strengthening WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies Tuesday 30 October 2012 Technical Specialist.
Indicators for monitoring and assessing pharmaceutical situation in countries Dr. Edelisa D. Carandang Drug Action Program (DAP) Essential Drugs and Medicines.
The Second Annual Medical Device Regulatory, Reimbursement and Compliance Congress Presented by J. Glenn George Thursday, March 29, 2007 Day II – Track.
Multi-country study on drug supply and distribution activities of faith-based supply organizations in sub-Saharan African countries, 2003 Sophie Logez.
IMPACT OF INTRODUCTION OF STATINS TO THE PRIVATE AND STATE SECTORS IN SRI LANKA ON UTILISATION, COST AND PRESCRIPTION PATTERN Galappatthy P Cooray BPR.
The Changing Face of EU Legislation Is the EU moving towards the FDA model of pharmaceutical legislation? By Robert Smith Director.
Systems that support electronically executed business transactions.
Introduction to the Australian Privacy Principles & the OAIC’s regulatory approach Privacy Awareness Week 2016.
, International Regulatory and Health Authorities Inspections Maria Santaella Sr. Quality Director Janssen Ortho LLC Jansen Cilag Manufacturing LLC Gurabo,
ADDRESSING PHARMACEUTICAL SUPPLY CHAIN NEEDS PRESENTATION TO HEALTH DONOR GROUP MEETING 8 July 2009.
Ground Rules Turn off your cell phones and turn on your minds. Ask questions as we cover the content. Sometimes we will use a “parking lot” for the questions.
Just in Time Labelling in the EEA Duncan J Donald VP Quality Europe Yourway transport Biopharma Services.
NANCY CHOBIN, RN, AAS, ACSP, CSPM, CFER CHOBIN & ASSOCIATES CONSULTING HOT TOPICS IN STERILIZATION AND DISINFECTION.
Storage, Labeling, Controlled Medications Guidance Training CFR § (b)(2)(3)(d)(e) F431.
Documentation –Part 2 Basic Principles of GMP Pharmaceutical Quality,
Health Supply Chain Management: Session 6: Facilities, Staffing and Procurement Ghana Nursing Schools.
RESERVE OR RETENTION SAMPLES PRESENTED BY N. SRIKANTH 1.
Ch 18: Pharmacy.
Presentation transcript:

Tsunami Drug Donations in Sri Lanka: Have the WHO Guidelines on Drug Donations been Effective in Meeting Public Health Pharmaceutical Needs in Times of Disaster? Rohini Fernandopulle 1,Hemantha Beneragama 2,Priyadarshini Gallappatthy 1,Nilesh Fernandopulle Department of Pharmacology, University of Colombo, Sri Lanka. 2 Ministry of Health, Sri Lanka.

What is known on medicines donation? 1980’s: main complaints: → 1.Arrived after or near expiration. 2.Inappropriate or unsuitable to the recipient country 3.Sent without first asking the recipient about their needs, without prior notification or shipping documents. 4.Were inadequately packaged or labelled with no prescriber or patient information. Development of guidelines for donors and recipients. Christian Medical Commission of the World Council of Churches; ↓ World Health Organization. Guidelines for Drug Donations. Geneva: WHO; WHO. Interagency Guidelines for Drug Donations; 1999.

Guideline Selection Donations should be based on expressed needs, appear in the national EML/WHO – EML. Donations of vaccines, be directed through a responsible agency. Quality assurance and shelf life Drugs issued to patients, or free samples to health professionals should not be donated. Donated drugs /INN should be approved for use in recipient country. Should have a remaining shelf-life of at least one year after arrival. Presentation, packaging and labelling Labelled in a language that is understood. Contain the INN, batch No. dosage form, strength, name of manufacturer, quantity in container, storage conditions and expiry date. The drugs should not be mixed with other supplies in the same carton Information and management. Costs of international and local transport, warehousing, port clearing, storage and handling should be paid by the donor.

Objectives and Methodology To categorise the medicines into the ATC drug classification system, to quantify and cost. To assess the level of adherence to the 1999 edition of the WHO Guidelines for drug donation. To generate evidence on effectiveness of the WHO guideline and make recommendations for a national policy on pharmaceutical donations. Study period: March to July Tools: questionnaires for MSD, hospital pharmacist, refugees. Database to inventory medicines. Adherence to guideline determined on: selection, quality assurance and shelf life, presentation packing and labelling, information and management. Destroying costs calculated using available documents.

Results: General Information 278 donors. 98 local individuals and organisations. 150 Foreign organisations, companies and individuals. From over 30 countries. 86% were under names of individuals. ≈50% were adhoc collections of medicines from individuals, transported via international relief organizations including the International Red Cross Federation. Quantity donated Total weight = 55 tons. (150 tons had expired and removed to be destroyed). Total number of single units = 248 × Number of INNs 769. Oral 71%, parenteral 15%. For 580,000 injured and displaced. Medicines per person = units.

Results: Selection Inappropriate medicines: etoposide, doxorubicin, flutamide, exemestane. Withdrawn drugs: dipyrone, cisapride dihydroergocristine. Radiolabelled Progesterone-Iodine 125. The top 5 categories J, N,C, A, R Vaccines:hepatitis A, B, influenza and tetanus toxoid were not sent from a responsible agency, UNICEF.

Results: Quality Assurance and Shelf Life 2% of medicines, labelled as free professional samples. 38% INNs not registered in Sri Lanka. Of the 55 metric tons, 28 metric tons (50.5%) did not have the expiry dates. 57% unusable from the start. Presentation, Packaging and Labelling

Information and management ≈150 metric tons of useless medicines destroyed at a cost of LKR 2.6 million. Cost of local transport, port clearing, storage and handling not by the donor. The monetary value claimed by one donor in USA had the purchasing power to buy 50% of the medicines for the state sector. But tsunami donations reduced the total drug budget (4.24 billion) in 2005 by only 4%. Storage Donated medicines were stored in hospital corridors, refugee camps, temples, churches, schools and hired warehouses.

Key messages Not having a national policy and guideline on medicines donation before the disaster was a major contributory factor. Soon after disaster it was known that most medicines were useless but country was help less; came unannounced to the MSD, airport or port. The WHO guideline is clear, comprehensive, practical and implementable if donors follow it and recipients enforce it. The WHO guideline has been available for 5 years, but it has not been effective in preventing useless donations in resource limited settings in times of disaster – Banda Aceh reported similar findings. Compliance with the guidelines resulted in 100% usable medicines. The other tsunami affected countries; India and Thailand immediately communicated via press release that they will not accept medicines as donations.

Policies and programs to improve donations Immediately Dissemination of the findings to all international organisations to prevent repetition. WHO to select medicines donation as a theme to raise awareness on the extent of the problem, as natural disasters are quite frequent. For WHO to send out short messages when severe disasters occur through the mass media on availability and adherence to the guideline. Long term Request National Drug Regulatory Authorities of donating countries to give a clearance certificate prior to shipping / airlifting, baggage carrying of medicines for donation based on the WHO guideline. Education of the public, customs officials and relevant organisations on Good Donation Practices.

Future research? Research on awareness of “Good Donation Practices” guideline at the level of the –Government –International Organisations –Public Public: maybe incorporated into the guideline on “How to investigate the use of medicines by consumers” Impact of useless donations on the environment. Long term continued WHO/ HAI to initiate a website for reporting bad donation practices. Local WHO offices to identify activities on raising awareness on good donation practices.